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• Users may download and print one copy of any publication from the public portal for the purpose of private study or research. • You may not further distribute the material or use it for any profit-making activity or commercial gain • You may freely distribute the URL identifying the publication in the public portal Take down policy If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim. Human foetal brain tissue has been used in experimental and clinical trials to develop and Huntington's disease. These pioneering clinical studies have shown proof of principle that cell replacement therapy can be effective and is worthwhile to develop as a therapeutic strategy for repairing the damaged brain [1-5]. However, because of the and quality-tested cell preparations from this source, there have been extensive efforts in investigating the potential use of alternative cell sources for generating a large number of transplantable, authentic neural progenitors and neurons. In this review we highlight the value of using human foetal tissue as reference material for quality control of acquired cell fate of in-vitro generated neurons pretransplantation and posttransplantation.
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To use any of these renewable sources of cells in the clinic, fully characterized a necessity. In addition, the authenticity and functionality of the stem cell-derived human mesencephalic dopamine (mesDA) neurons needs to be fully established in vitro as well as in vivo, in animal models. We argue that human foetal tissue material serve as a valuable resource and provides a 'golden standard' comparison when validating ing the capacity of in-vitro generated cells upon transplantation ( Fig. 1 ).
Human foetal tissue for quality control (qc) of in-vitro generated cells pretransplanprogenitors have been validated on human foetal tissue and can be used to validate the quality of protocols aiming at generating mesDA progenitors in vitro (a). Moreover, transplanted foetal mesDA progenitors can serve as a quality control (qc) of in-vitro generated mesDA progenitors post-transplantation, in terms of expected expression of mature disease animal models (b).
Quality control of in-vitro generated cells
is very important to analyse the quality and determine the authenticity of these cells.
brain cells from terminations of pregnancy, presents the opportunity to use these cells as a 'gold standard' for direct comparison with any cells generated in a culture dish ( Fig. 1a ). neural progenitors generated in vitro is to analyse the gene and protein expression of cells, protein expression analysis presents particular challenges. ly available and have been extensively tested and used in developmental studies of ies has not been validated on human brain tissue. The direct use of these antibodies on human cells can, therefore, give misleading data, by providing false positive or false ferent regions of the human foetal brain, as well as in primary culture of human foetal found that less than 40% of these reliably label the correct cell population when tested on human embryos or human primary cultures. We here provide a list of antibodies sue (Table 1 ).
Specie differences observed between mouse and human. Schematic illustration of some species differences between mouse and human observed in our comparative studies on the human and mouse ventral midbrain [24, 25] .
Secondly, although there are extensive similarities in the expression pattern of genes and proteins between species, differences have been observed between rodents and humans [22] [23] [24] [25] . Differences observed in our studies are summarized in Fig.  3 . For example, in the murine ventral midbrain (VM), brain lipid binding protein highly expressed within the mesDA neuron progenitor domain but absent from the lateral cell population [25] . Species variation was also observed in the distribution of the proneural gene, Neurogenin 2 (NGN2) expressing cells in the ventricular zone of the VM, but not in the spinal cord [24] . Thus, the possible species difference in the temporal and spatial gene and protein expression is an important aspect to be aware of and to consider when analysing the identity of in-vitro generated cells.
In-vivo analysis
Human foetal cells also serve as a valuable and necessary reference material when analysing in-vitro generated cells after transplantation (Fig. 1b) . Human cells mature slowly in vivo [26, 27] and thus long time points are needed for complete assessment, but xenotransplantation in rodent models are connected with concerns of immunosuppression to ensure graft survival. This can be addressed in several ways, including the use of athymic nude rats who have a compromised immune system bebut to immunosuppress them with daily intraperitoneal injections of ciclosporin A. Daily immunosuppression can, however, only be maintained for a certain time before the animal begins to suffer side effects from the drug treatment and/or the administra-There are few studies where a time course of improvement of lesion-induced behav-transplantation [7] . Thus using a model with daily immunosuppression allows us to observe the initial phase of graft-induced behavioural recovery mediated by human be performed then athymic nude rats become more attractive, but they are surrounded with cost, logistic and practical issues regarding their housing, handling and experimental use. Behavioural assessments using nude rats are not well established so some initial caution would be advised when initiating studies using such strains.
munostained for tyrosine hydroxylase (TH) depict a transplant of human foetal ventral mid-veals a mixture of more mature dopamine neurons with a large angular soma, and more imin athymic nude rats, human dopamine neurons display a more typical mature morphology as in clinical trials, human foetal VM tissue can serve as a valuable predictive control for the in-vitro generated mesDA-patterned cells in terms of what to expect from survival, neuronal composition and innervation capacity also at early time points when behavioural recovery cannot be measured. In Fig. 4 we depict a transplant of a 6 despite most neurons still having an immature neuronal morphology (Fig. 4b and c ).
to observe mature neuronal morphology characteristic of mesDA neurons (Fig. 4d) .
In our experience, cells that have similar phenotype in terms of morphology, in-to become functional when left to mature long term. Thus, short-term comparative analysis serves as a prediction of long-term differentiation and function. In a recent study, we performed a side-by-side analysis of grafted human foetal and hESC-de-from hESCs were indistinguishable from those derived from foetal VM. Both sourc-LMX1A, EN-1 and NURR1, had mature neuronal morphology and innervated similar host structures. The hESC-derived neurons maintained their acquired in-vitro regional identity post-transplantation, and terminally differentiated into functional mesDA tity have been made using similar in-vitro protocols [9, 30] .
In summary, human foetal tissue has in many aspects been shown to serve as an important source of material for quality control of in-vitro generated cells. Because thenticity and function in vitro and in animal models is not possible. A side-by-side disease patients, may be the best way to predict clinical performance and decide on
